Projects per year
Personal profile
Education
- 2009 Ph.D., Graduate Institute of Clinical Medicine, Taipei Medical University
- 1985-1992 M.D., School of Medicine, National Taiwan University
Experience
- 2020.11- Director, Department of Nuclear Medicine, Taipei Medical University Hospital
- 2019- Vice Superintendent, Taipei Medical University Hospital
- 2017.08- Professor, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2016.06-2017.07 Deputy Director, School of Medicine, College of Medicine, Taipei Medical University
- 2015.08- Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2015.08- Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
- 2015 Vice Chairman, Department of Surgery, Taipei Medical University Hospital
- 2015 Chairman, Department of Quality Management, Taipei Medical University Hospital
- 2014.08- Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 2014.02- Ph.D. Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical university
- 2012.08-2015.07 Associate Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2009.08-2012.07 Assistant Professor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2008 Chief, Division of General Surgery, Taipei Medical University Hospital
- 2006 Attending Doctor, General Surgery, Taipei Medical University Hospital
- 2006.02-2009.07 Instructor, Department of Surgery, School of Medicine, College of Medicine, Taipei Medical University
- 2005.12-2006.05 Director, Division of Rectal Surgery, Min-Sheng Hospital
- 2004.07-2005.11 Director, Division of General Surgery, En Chu Kong Hospital
- 2003.07-2004.06 Director, Division of Rectal Surgery, En Chu Kong Hospital
- 1997.07-2006.06 Attending Physician, Department of Surgery, En Chu Kong Hospital
- 1992.07-1997.06 Resident Physician, Department of Surgery, National Taiwan University Hospital
Awards
- 2015 Faculty Award of Taipei Medical University
- 2015 Distinguished Teaching Award of College of Medicine, Taipei Medical University
- 2013 Best Advisor Award of College of Medicine, Taipei Medical University
- 2011 The excellent thesis of the year 2010 by international college of surgeons
Research Interests
- Cancer molecular biology
- Signal transduction
- ER stress and metastasis
- Colorectal Surgery
URL
Fingerprint
Dive into the research topics where Po-Li Wei is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 12 Finished
-
探討PCTK1激?蛋白在大腸直腸癌發展的角色及其調控機制(延續計畫)(3/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
To Study the Role of Pctk1 in the Progression of Colorectal Cancer and Molecular Mechanism (Continuation Project)(2/3)
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
To Study the Role of Pctk1 in the Progression of Colorectal Cancer and Molecular Mechanism (Continuation Project)(1/3)
8/1/18 → 7/31/19
Project: A - Government Institution › b - Ministry of Science and Technology
-
To Study the Role of Pctk1 in the Progression of Colorectal Cancer and Molecular Mechanism
8/1/17 → 7/31/18
Project: A - Government Institution › b - Ministry of Science and Technology
-
Immunogenomics and PDX models for precision medicine on CRC
1/1/17 → 12/31/17
Project: A - Government Institution › c - Ministry of Health and Welfare
-
Author Correction: Comparison of clinical outcomes between laparoscopic and open surgery for left-sided colon cancer: a nationwide population-based study (Scientific Reports, (2020), 10, 1, (75), 10.1038/s41598-019-57059-6)
Huang, Y. M., Lee, Y. W., Huang, Y. J. & Wei, P. L., Dec 2021, In: Scientific Reports. 11, 1, 9084.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Corrigendum to "Surgical outcomes of robotic transanal minimally invasive surgery for selected rectal neoplasms: A single-hospital experience"[ASJSUR 43(2019) 290-296/675
Huang, Y. J., Huang, Y. M., Wang, W. L., Tong, Y. S., Hsu, W. & Wei, P. L., Jun 1 2021, In: Asian Journal of Surgery. 44, 6, p. 937 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Corrigendum to “Early versus delayed surgery after short-course radiotherapy for rectal cancer: A network meta-analysis of randomized controlled trials” [Asian J Surg S1015-9584 (19) (2019) 30824-3] (Asian Journal of Surgery (2020) 43(8) (810–818), (S1015958419308243), (10.1016/j.asjsur.2019.10.006))
Huang, Y. J., Tai, C., Kang, Y. N. & Wei, P. L., Feb 2021, In: Asian Journal of Surgery. 44, 2, p. 526 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Corrigendum to “Effects of laparoscopic vs robotic-assisted mesorectal excision for rectal cancer: An update systematic review and meta-analysis of randomized controlled trials”. [Asian J Surg. 42 (6) 2019 Jun 657-666](S1015958418305384)(10.1016/j.asjsur.2018.11.007)
Huang, Y. J., Kang, Y. N., Huang, Y. M., Wu, A. T., Wang, W. & Wei, P. L., Jan 2021, In: Asian Journal of Surgery. 44, 1, p. 429 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Corrigendum to “Surgical outcomes of robotic transanal minimally invasive surgery for selected rectal neoplasms: A single-hospital experience” [Asian J Surg. 43 (1) (2020 Jan) 290–296] (Asian Journal of Surgery (2020) 43(1) (290–296), (S1015958419301770), (10.1016/j.asjsur.2019.04.007))
Huang, Y. J., Huang, Y. M., Wang, W. L., Tong, Y. S., Hsu, W. & Wei, P. L., Feb 2021, In: Asian Journal of Surgery. 44, 2, p. 525 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access
Datasets
-
Additional file 2: Figure S1. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huang, Y. (Contributor), Yang, C. (Contributor), Wei, P. (Contributor), Huynh, T. (Contributor), Whang-Peng, J. (Contributor), Meng, T. (Contributor), Hsiao, M. (Contributor), Tzeng, Y. (Contributor), Wu, T. A. (Contributor) & Yen, Y. (Contributor), Unknown Publisher, Feb 28 2017
DOI: 10.6084/m9.figshare.c.3704533_d1.v1, https://springernature.figshare.com/articles/presentation/Additional_file_2_Figure_S1_of_Ovatodiolide_suppresses_colon_tumorigenesis_and_prevents_polarization_of_M2_tumor-associated_macrophages_through_YAP_oncogenic_pathways/4701505/1
Dataset
-
Additional file 1: Figure S2. of Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huang, Y. (Contributor), Yang, C. (Contributor), Wei, P. (Contributor), Huynh, T. (Contributor), Whang-Peng, J. (Contributor), Meng, T. (Contributor), Hsiao, M. (Contributor), Tzeng, Y. (Contributor), Wu, T. A. (Contributor) & Yen, Y. (Contributor), Unknown Publisher, Feb 28 2017
DOI: 10.6084/m9.figshare.c.3704533_d2.v1, https://springernature.figshare.com/articles/presentation/Additional_file_1_Figure_S2_of_Ovatodiolide_suppresses_colon_tumorigenesis_and_prevents_polarization_of_M2_tumor-associated_macrophages_through_YAP_oncogenic_pathways/4701517/1
Dataset
-
Additional file 1: of Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial
Yeh, Y. (Contributor), Tsai, H. (Contributor), Huang, C. (Contributor), Wei, P. (Contributor), Sung, Y. (Contributor), Tang, H. (Contributor) & Wang, J. (Contributor), Unknown Publisher, Apr 26 2017
DOI: 10.6084/m9.figshare.c.3751544_d1.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Maintenance_tegafur-uracil_versus_observation_following_an_adjuvant_oxaliplatin-based_regimen_in_patients_with_stage_III_colon_cancer_after_radical_resection_study_protocol_for_a_randomized_controlled_trial/4909706/1
Dataset
-
Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huang, Y. (Contributor), Yang, C. (Contributor), Wei, P. (Contributor), Huynh, T. (Contributor), Whang-Peng, J. (Contributor), Meng, T. (Contributor), Hsiao, M. (Contributor), Tzeng, Y. (Contributor), Wu, T. A. (Contributor) & Yen, Y. (Contributor), Unknown Publisher, Feb 28 2017
DOI: 10.6084/m9.figshare.c.3704533.v1, https://figshare.com/collections/Ovatodiolide_suppresses_colon_tumorigenesis_and_prevents_polarization_of_M2_tumor-associated_macrophages_through_YAP_oncogenic_pathways/3704533/1
Dataset
-
Maintenance tegafur-uracil versus observation following an adjuvant oxaliplatin-based regimen in patients with stage III colon cancer after radical resection: study protocol for a randomized controlled trial
Yeh, Y. (Contributor), Tsai, H. (Contributor), Huang, C. (Contributor), Wei, P. (Contributor), Sung, Y. (Contributor), Tang, H. (Contributor) & Wang, J. (Contributor), Unknown Publisher, Apr 26 2017
DOI: 10.6084/m9.figshare.c.3751544.v1, https://figshare.com/collections/Maintenance_tegafur-uracil_versus_observation_following_an_adjuvant_oxaliplatin-based_regimen_in_patients_with_stage_III_colon_cancer_after_radical_resection_study_protocol_for_a_randomized_controlled_trial/3751544/1
Dataset